Methylation-sensitive Regulation of TMS1/ASC by the Ets Factor, GA-binding Protein-α
Epigenetic silencing involving the aberrant DNA methylation of promoter-associated CpG islands is one mechanism leading to the inactivation of tumor suppressor genes in human cancers. However, the molecular mechanisms underlying this event remains poorly understood. TMS1/ASC is a novel proapoptotic...
Saved in:
Published in | The Journal of biological chemistry Vol. 284; no. 22; pp. 14698 - 14709 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
29.05.2009
American Society for Biochemistry and Molecular Biology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Epigenetic silencing involving the aberrant DNA methylation of promoter-associated CpG islands is one mechanism leading to the inactivation of tumor suppressor genes in human cancers. However, the molecular mechanisms underlying this event remains poorly understood. TMS1/ASC is a novel proapoptotic signaling factor that is subject to epigenetic silencing in human breast and other cancers. The TMS1 promoter is embedded within a CpG island that is unmethylated in normal cells and is spanned by three DNase I-hypersensitive sites (HS). Silencing of TMS1 in cancer cells is accompanied by local alterations in histone modification, remodeling of the HS, and hypermethylation of DNA. In this study, we probed the functional significance of the CpG island-specific HS. We identified a methylation-sensitive complex that bound a 55-bp intronic element corresponding to HS2. Affinity chromatography and mass spectrometry identified a component of this complex to be the GA-binding protein (GABP) α. Supershift analysis indicated that the GABPα binding partner, GABPβ1, was also present in the complex. The HS2 element conferred a 3-fold enhancement in TMS1 promoter activity, which was dependent on both intact tandem ets binding sites and the presence of GABPα/β1 in trans. GABPα was selectively enriched at HS2 in human cells, and its occupancy was inversely correlated with CpG island methylation. Down-regulation of GABPα led to a concomitant decrease in TMS1 expression. These data indicate that the intronic HS2 element acts in cis to maintain transcriptional competency at the TMS1 locus and that this activity is mediated by the ets transcription factor, GABPα. |
---|---|
AbstractList | Epigenetic silencing involving the aberrant DNA methylation of
promoter-associated CpG islands is one mechanism leading to the inactivation
of tumor suppressor genes in human cancers. However, the molecular mechanisms
underlying this event remains poorly understood.
TMS1
/
ASC
is
a novel proapoptotic signaling factor that is subject to epigenetic silencing
in human breast and other cancers. The
TMS1
promoter is embedded
within a CpG island that is unmethylated in normal cells and is spanned by
three DNase I-hypersensitive sites (HS). Silencing of
TMS1
in cancer
cells is accompanied by local alterations in histone modification, remodeling
of the HS, and hypermethylation of DNA. In this study, we probed the
functional significance of the CpG island-specific HS. We identified a
methylation-sensitive complex that bound a 55-bp intronic element
corresponding to HS2. Affinity chromatography and mass spectrometry identified
a component of this complex to be the GA-binding protein (GABP) α.
Supershift analysis indicated that the GABPα binding partner,
GABPβ1, was also present in the complex. The HS2 element conferred a
3-fold enhancement in
TMS1
promoter activity, which was dependent on
both intact tandem ets binding sites and the presence of GABPα/β1
in
trans
. GABPα was selectively enriched at HS2 in human cells,
and its occupancy was inversely correlated with CpG island methylation.
Down-regulation of GABPα led to a concomitant decrease in
TMS1
expression. These data indicate that the intronic HS2 element acts in
cis
to maintain transcriptional competency at the
TMS1
locus
and that this activity is mediated by the ets transcription factor,
GABPα. Epigenetic silencing involving the aberrant DNA methylation of promoter-associated CpG islands is one mechanism leading to the inactivation of tumor suppressor genes in human cancers. However, the molecular mechanisms underlying this event remains poorly understood. TMS1/ASC is a novel proapoptotic signaling factor that is subject to epigenetic silencing in human breast and other cancers. The TMS1 promoter is embedded within a CpG island that is unmethylated in normal cells and is spanned by three DNase I-hypersensitive sites (HS). Silencing of TMS1 in cancer cells is accompanied by local alterations in histone modification, remodeling of the HS, and hypermethylation of DNA. In this study, we probed the functional significance of the CpG island-specific HS. We identified a methylation-sensitive complex that bound a 55-bp intronic element corresponding to HS2. Affinity chromatography and mass spectrometry identified a component of this complex to be the GA-binding protein (GABP) α. Supershift analysis indicated that the GABPα binding partner, GABPβ1, was also present in the complex. The HS2 element conferred a 3-fold enhancement in TMS1 promoter activity, which was dependent on both intact tandem ets binding sites and the presence of GABPα/β1 in trans. GABPα was selectively enriched at HS2 in human cells, and its occupancy was inversely correlated with CpG island methylation. Down-regulation of GABPα led to a concomitant decrease in TMS1 expression. These data indicate that the intronic HS2 element acts in cis to maintain transcriptional competency at the TMS1 locus and that this activity is mediated by the ets transcription factor, GABPα. Epigenetic silencing involving the aberrant DNA methylation of promoter-associated CpG islands is one mechanism leading to the inactivation of tumor suppressor genes in human cancers. However, the molecular mechanisms underlying this event remains poorly understood. TMS1/ASC is a novel proapoptotic signaling factor that is subject to epigenetic silencing in human breast and other cancers. The TMS1 promoter is embedded within a CpG island that is unmethylated in normal cells and is spanned by three DNase I-hypersensitive sites (HS). Silencing of TMS1 in cancer cells is accompanied by local alterations in histone modification, remodeling of the HS, and hypermethylation of DNA. In this study, we probed the functional significance of the CpG island-specific HS. We identified a methylation-sensitive complex that bound a 55-bp intronic element corresponding to HS2. Affinity chromatography and mass spectrometry identified a component of this complex to be the GA-binding protein (GABP) alpha. Supershift analysis indicated that the GABPalpha binding partner, GABPbeta1, was also present in the complex. The HS2 element conferred a 3-fold enhancement in TMS1 promoter activity, which was dependent on both intact tandem ets binding sites and the presence of GABPalpha/beta1 in trans. GABPalpha was selectively enriched at HS2 in human cells, and its occupancy was inversely correlated with CpG island methylation. Down-regulation of GABPalpha led to a concomitant decrease in TMS1 expression. These data indicate that the intronic HS2 element acts in cis to maintain transcriptional competency at the TMS1 locus and that this activity is mediated by the ets transcription factor, GABPalpha. Epigenetic silencing involving the aberrant DNA methylation of promoter-associated CpG islands is one mechanism leading to the inactivation of tumor suppressor genes in human cancers. However, the molecular mechanisms underlying this event remains poorly understood. TMS1/ASC is a novel proapoptotic signaling factor that is subject to epigenetic silencing in human breast and other cancers. The TMS1 promoter is embedded within a CpG island that is unmethylated in normal cells and is spanned by three DNase I-hypersensitive sites (HS). Silencing of TMS1 in cancer cells is accompanied by local alterations in histone modification, remodeling of the HS, and hypermethylation of DNA. In this study, we probed the functional significance of the CpG island-specific HS. We identified a methylation-sensitive complex that bound a 55-bp intronic element corresponding to HS2. Affinity chromatography and mass spectrometry identified a component of this complex to be the GA-binding protein (GABP) alpha. Supershift analysis indicated that the GABPalpha binding partner, GABPbeta1, was also present in the complex. The HS2 element conferred a 3-fold enhancement in TMS1 promoter activity, which was dependent on both intact tandem ets binding sites and the presence of GABPalpha/beta1 in trans. GABPalpha was selectively enriched at HS2 in human cells, and its occupancy was inversely correlated with CpG island methylation. Down-regulation of GABPalpha led to a concomitant decrease in TMS1 expression. These data indicate that the intronic HS2 element acts in cis to maintain transcriptional competency at the TMS1 locus and that this activity is mediated by the ets transcription factor, GABPalpha.Epigenetic silencing involving the aberrant DNA methylation of promoter-associated CpG islands is one mechanism leading to the inactivation of tumor suppressor genes in human cancers. However, the molecular mechanisms underlying this event remains poorly understood. TMS1/ASC is a novel proapoptotic signaling factor that is subject to epigenetic silencing in human breast and other cancers. The TMS1 promoter is embedded within a CpG island that is unmethylated in normal cells and is spanned by three DNase I-hypersensitive sites (HS). Silencing of TMS1 in cancer cells is accompanied by local alterations in histone modification, remodeling of the HS, and hypermethylation of DNA. In this study, we probed the functional significance of the CpG island-specific HS. We identified a methylation-sensitive complex that bound a 55-bp intronic element corresponding to HS2. Affinity chromatography and mass spectrometry identified a component of this complex to be the GA-binding protein (GABP) alpha. Supershift analysis indicated that the GABPalpha binding partner, GABPbeta1, was also present in the complex. The HS2 element conferred a 3-fold enhancement in TMS1 promoter activity, which was dependent on both intact tandem ets binding sites and the presence of GABPalpha/beta1 in trans. GABPalpha was selectively enriched at HS2 in human cells, and its occupancy was inversely correlated with CpG island methylation. Down-regulation of GABPalpha led to a concomitant decrease in TMS1 expression. These data indicate that the intronic HS2 element acts in cis to maintain transcriptional competency at the TMS1 locus and that this activity is mediated by the ets transcription factor, GABPalpha. |
Author | Lucas, Mary E. Crider, Krista S. Powell, Doris R. Kapoor-Vazirani, Priya Vertino, Paula M. |
AuthorAffiliation | Graduate Program in Genetics and Molecular Biology and § Departments of Radiation Oncology and Hematology and Medical Oncology, the Winship Cancer Institute, Emory University, Atlanta, Georgia 30322 |
AuthorAffiliation_xml | – name: Graduate Program in Genetics and Molecular Biology and § Departments of Radiation Oncology and Hematology and Medical Oncology, the Winship Cancer Institute, Emory University, Atlanta, Georgia 30322 |
Author_xml | – sequence: 1 givenname: Mary E. surname: Lucas fullname: Lucas, Mary E. organization: Graduate Program in Genetics and Molecular Biology – sequence: 2 givenname: Krista S. surname: Crider fullname: Crider, Krista S. organization: Graduate Program in Genetics and Molecular Biology – sequence: 3 givenname: Doris R. surname: Powell fullname: Powell, Doris R. organization: Departments of Radiation Oncology and Hematology and Medical Oncology, the Winship Cancer Institute, Emory University, Atlanta, Georgia 30322 – sequence: 4 givenname: Priya surname: Kapoor-Vazirani fullname: Kapoor-Vazirani, Priya organization: Departments of Radiation Oncology and Hematology and Medical Oncology, the Winship Cancer Institute, Emory University, Atlanta, Georgia 30322 – sequence: 5 givenname: Paula M. surname: Vertino fullname: Vertino, Paula M. email: pvertin@emory.edu organization: Graduate Program in Genetics and Molecular Biology |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19324871$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kVFv0zAUhS00xLrBK4-QJ55I52sncfKCVFXbQFoFoqvEm-U4N62n1B62W6k_iz-y3zRDBgOk-cWS_Z1zr845IUfWWSTkNdApUFGc3bR6umgoAC0Ypc_IBGjNc17CtyMyoZRB3rCyPiYnIdzQdIoGXpBjaDgragETslpg3BwGFY2zeUAbTDR7zL7iejc-Zq7PrhdLOJst51l7yOIGs_MYsgulo_Pvs8tZ3hrbGbvOvngX0dj87sdL8rxXQ8BXD_cpWV2cX88_5lefLz_NZ1e5LiqIOaq24WVPq1o0omm0BlpC1VOueM3assSaa8ZaIUSnE9hCrwVtsQNQXFSs5afkw-h7u2u32Gm00atB3nqzVf4gnTLy3x9rNnLt9pJVdVmVLBm8ezDw7vsOQ5RbEzQOg7LodkFWgtUFFFUC3_w96c-I30kmYDoC2rsQPPaPCJU_q5KpKvlYVRIU_wm0ib8iT5ua4WnZ21HWKyfV2psgV0tGgVOoOBeiTEQ9EpiS3xv0MmiDVmNnPOooO2eeMr8Hv6Gzfg |
CitedBy_id | crossref_primary_10_1016_j_bbagrm_2015_09_005 crossref_primary_10_1074_jbc_M111_316422 crossref_primary_10_1186_s13059_015_0827_6 crossref_primary_10_1074_jbc_M109_088740 crossref_primary_10_1093_nar_gkw528 crossref_primary_10_1155_2013_689798 crossref_primary_10_1007_s00018_013_1524_9 crossref_primary_10_1038_s41422_020_0295_8 crossref_primary_10_17533_udea_iatreia_v28n2a07 crossref_primary_10_1158_2159_8290_CD_20_1213 crossref_primary_10_1074_jbc_M115_646737 crossref_primary_10_1073_pnas_1121260109 crossref_primary_10_1042_CS20130258 crossref_primary_10_4167_jbv_2011_41_3_133 |
Cites_doi | 10.1038/nature07710 10.1038/sj.cdd.4402194 10.1038/sj.onc.1204890 10.1074/jbc.M606803200 10.1038/nmeth.1246 10.1210/endo.140.5.6710 10.1128/JVI.74.11.4988-4998.2000 10.4049/jimmunol.171.11.6154 10.1101/gad.1561707 10.1016/0959-437X(93)90027-M 10.1074/jbc.M213063200 10.1038/sj.onc.1206430 10.1210/mend.12.8.0142 10.1093/nar/24.24.4954 10.1128/jvi.70.4.2260-2268.1996 10.1016/j.jmb.2008.01.054 10.1128/MCB.15.10.5355 10.1016/S0006-291X(03)00309-7 10.1038/ng1158 10.1158/0008-5472.CAN-08-0141 10.1016/S0002-9440(10)63376-7 10.1101/gad.6.12b.2502 10.1056/NEJMra023075 10.1128/MCB.24.13.5844-5849.2004 10.1038/sj.onc.1209684 10.1074/jbc.M109809200 10.1016/S0378-1119(97)00377-6 10.1158/0008-5472.CAN-08-2351 10.1002/ijc.11206 10.1016/j.canlet.2003.08.027 10.1023/B:APPT.0000012117.32430.0c 10.1093/nar/23.23.4785 10.1016/j.cell.2007.09.026 10.1093/hmg/11.20.2479 10.1038/sj.onc.1205153 10.1016/S0006-291X(02)00384-4 10.1038/ncb1087 10.1002/ijc.11376 10.1016/0959-437X(95)80044-1 10.1038/ncb1548 10.1016/j.bcmd.2003.09.005 10.1002/pros.20371 10.1074/jbc.272.33.20850 10.1128/MCB.26.8.3060-3070.2006 10.1038/sj.onc.1209965 10.1021/bi00206a017 |
ContentType | Journal Article |
Copyright | 2009 © 2009 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. Copyright © 2009, The American Society for Biochemistry and Molecular Biology, Inc. |
Copyright_xml | – notice: 2009 © 2009 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. – notice: Copyright © 2009, The American Society for Biochemistry and Molecular Biology, Inc. |
DBID | 6I. AAFTH FBQ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1074/jbc.M901104200 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access AGRIS CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1083-351X |
EndPage | 14709 |
ExternalDocumentID | PMC2685652 19324871 10_1074_jbc_M901104200 US201301633775 S0021925819820811 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: F31 GM078787 – fundername: NCI NIH HHS grantid: R01 CA077337 – fundername: NCI NIH HHS grantid: 2R01 CA077337 – fundername: NIGMS NIH HHS grantid: T32 GM008490 |
GroupedDBID | --- -DZ -ET -~X .55 0SF 18M 29J 2WC 34G 39C 4.4 53G 5BI 5GY 5RE 5VS 6I. 79B 85S AAEDW AAFTH AAFWJ AARDX AAXUO ABDNZ ABOCM ABPPZ ABRJW ACGFO ACNCT ADBBV ADIYS ADNWM AENEX AEXQZ AFFNX AFMIJ AFOSN AFPKN ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BAWUL BTFSW C1A CJ0 CS3 DIK DU5 E3Z EBS EJD F20 F5P FDB FRP GROUPED_DOAJ GX1 HH5 HYE IH2 KQ8 L7B MVM N9A OK1 P-O P0W P2P R.V RHF RHI RNS ROL RPM SJN TBC TN5 TR2 UHB UKR UPT VQA W8F WH7 WOQ X7M XFK XSW YQT YSK YWH YZZ ZA5 ZE2 ~02 ~KM .GJ 186 3O- 41~ 6TJ AAYJJ AAYOK ABFSI ABPTK ABTAH ACSFO ACYGS AEQTP AFDAS AI. E.L FA8 FBQ J5H NHB OHT QZG UQL VH1 WHG XJT Y6R YYP ZGI ZY4 .7T 0R~ AALRI AAYWO AAYXX ACVFH ADCNI ADVLN ADXHL AEUPX AFPUW AIGII AITUG AKBMS AKRWK AKYEP CITATION H13 CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c461t-eab935f06879799cc10516f03a382b55e83c22b777dc935b1fc70bed11a3762b3 |
ISSN | 0021-9258 |
IngestDate | Thu Aug 21 18:40:13 EDT 2025 Mon Aug 18 04:33:18 EDT 2025 Mon Jul 21 05:29:15 EDT 2025 Tue Jul 01 01:53:10 EDT 2025 Thu Apr 24 22:53:12 EDT 2025 Wed Dec 27 19:32:19 EST 2023 Fri Feb 23 02:45:18 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 22 |
Language | English |
License | This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0 https://www.elsevier.com/tdm/userlicense/1.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c461t-eab935f06879799cc10516f03a382b55e83c22b777dc935b1fc70bed11a3762b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 The on-line version of this article (available at http://www.jbc.org) contains supplemental Table S1. Georgia Cancer Coalition Distinguished Cancer Scholar. To whom correspondence should be addressed: 1365-C Clifton Rd., NE, Rm. 4086, Atlanta, GA 30322. Tel.: 404-778-3119; Fax: 404-778-5530; E-mail: pvertin@emory.edu. Current address: National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control, Atlanta, GA 30033. This work was supported, in whole or in part, by National Institutes of Health NCI Grant 2RO1 CA077337. Supported by National Research Service Award Minorities Access to Research Careers Predoctoral Fellowship F31 GM078787. |
OpenAccessLink | https://dx.doi.org/10.1074/jbc.M901104200 |
PMID | 19324871 |
PQID | 67284146 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2685652 proquest_miscellaneous_67284146 pubmed_primary_19324871 crossref_primary_10_1074_jbc_M901104200 crossref_citationtrail_10_1074_jbc_M901104200 fao_agris_US201301633775 elsevier_sciencedirect_doi_10_1074_jbc_M901104200 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-05-29 |
PublicationDateYYYYMMDD | 2009-05-29 |
PublicationDate_xml | – month: 05 year: 2009 text: 2009-05-29 day: 29 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of biological chemistry |
PublicationTitleAlternate | J Biol Chem |
PublicationYear | 2009 |
Publisher | Elsevier Inc American Society for Biochemistry and Molecular Biology |
Publisher_xml | – name: Elsevier Inc – name: American Society for Biochemistry and Molecular Biology |
References | Stone, Bobo, Brat, Devi, Van Meir, Vertino (bib10) 2004; 165 Fernandes-Alnemri, Wu, Yu, Datta, Miller, Jankowski, Rosenberg, Zhang, Alnemri (bib15) 2007; 14 Hollenhorst, Shah, Hopkins, Graves (bib36) 2007; 21 Shiohara, Taniguchi, Masumoto, Yasui, Koike, Komiyama, Sagara (bib13) 2002; 293 Stimson, Vertino (bib21) 2002; 277 Schmitz, Short, Ammerpohl, Asbrand, Nickel, Renkawitz (bib47) 1997; 272 Swigut, Wysocka (bib4) 2007; 131 Ohtsuka, Ryu, Minamishima, Macip, Sagara, Nakayama, Aaronson, Lee (bib38) 2004; 6 Yokomori, Kobayashi, Moore, Sueyoshi, Negishi (bib44) 1995; 15 Kapoor-Vazirani, Kagey, Powell, Vertino (bib22) 2008; 68 Sawa, Goto, Suzuki, Watanabe, Sawada, Handa (bib26) 1996; 24 Flory, Hoffmeyer, Smola, Rapp, Bruder (bib30) 1996; 70 Nickel, Short, Schmitz, Eggert, Renkawitz (bib43) 1995; 23 Atlas, Stramwasser, Mueller (bib32) 2001; 20 Virbasius, Scarpulla (bib25) 1991; 11 Masumoto, Dowds, Schaner, Chen, Ogura, Li, Zhu, Katsuyama, Sagara, Taniguchi, Gumucio, Nunez, Inohara (bib18) 2003; 303 Conway, McConnell, Bowring, Donald, Warren, Vertino (bib8) 2000; 60 Valouev, Johnson, Sundquist, Medina, Anton, Batzoglou, Myers, Sidow (bib27) 2008; 5 Kang, Nelson, Mackereth, Scharpf, Graves, McIntosh (bib40) 2008; 377 Hashimshony, Zhang, Keshet, Bustin, Cedar (bib48) 2003; 34 Song, Stirzaker, Harrison, Melki, Clark (bib49) 2002; 21 Hoare, Copland, Wood, Jeng, Izban, Soloff (bib33) 1999; 140 Aurrekoetxea-Hernandez, Buetti (bib28) 2000; 74 Parsons, Vertino (bib17) 2006; 25 Ristevski, O'Leary, Thornell, Owen, Kola, Hertzog (bib35) 2004; 24 Herman, Baylin (bib3) 2003; 349 Fernandes-Alnemri, Yu, Datta, Wu, Alnemri (bib16) 2009; 458 Yang, Mott, Rosmarin (bib31) 2007; 9 Parsons, Patel, Brat, Colbert, Vertino (bib20) 2009; 69 Zhao, Kim, Song, Dean (bib6) 2006; 281 Rosmarin, Resendes, Yang, McMillan, Fleming (bib24) 2004; 32 Cardot, Pastier, Lacorte, Mangeney, Zannis, Chambaz (bib42) 1994; 33 Levine, Stimson-Crider, Vertino (bib23) 2003; 22 Tate, Bird (bib5) 1993; 3 Schweppe, Melton, Brodsky, Aveline, Resing, Ahn, Gutierrez-Hartmann (bib34) 2003; 278 Virmani, Rathi, Sugio, Sathyanarayana, Toyooka, Kischel, Tonk, Padar, Takahashi, Roth, Euhus, Minna, Gazdar (bib11) 2003; 106 Stehlik, Lee, Dorfleutner, Stassinopoulos, Sagara, Reed (bib14) 2003; 171 Plass (bib1) 2002; 11 Yokoyama, Sagara, Guan, Masumoto, Takeoka, Komiyama, Miyata, Higuchi, Taniguchi (bib12) 2003; 202 McConnell, Vertino (bib37) 2004; 9 Ammerpohl, Short, Asbrand, Schmitz, Renkawitz (bib46) 1997; 200 Yokomori, Tawata, Saito, Shimura, Onaya (bib45) 1998; 12 Imaki, Nakayama, Delehouzee, Handa, Kitagawa, Kamura, Nakayama (bib41) 2003; 63 Hasegawa, Kawase, Inohara, Imamura, Yeh, Kinoshita, Suda (bib19) 2007; 26 Brown, McKnight (bib29) 1992; 6 Guan, Sagara, Yokoyama, Koganehira, Oguchi, Saida, Taniguchi (bib9) 2003; 107 Cross, Bird (bib2) 1995; 5 Collard, Harya, Monzon, Maier, O'Keefe (bib7) 2006; 66 Resendes, Rosmarin (bib39) 2006; 26 Aurrekoetxea-Hernandez (10.1074/jbc.M901104200_bib28) 2000; 74 Levine (10.1074/jbc.M901104200_bib23) 2003; 22 Shiohara (10.1074/jbc.M901104200_bib13) 2002; 293 Stone (10.1074/jbc.M901104200_bib10) 2004; 165 Fernandes-Alnemri (10.1074/jbc.M901104200_bib15) 2007; 14 Hashimshony (10.1074/jbc.M901104200_bib48) 2003; 34 Sawa (10.1074/jbc.M901104200_bib26) 1996; 24 Stehlik (10.1074/jbc.M901104200_bib14) 2003; 171 Schweppe (10.1074/jbc.M901104200_bib34) 2003; 278 Flory (10.1074/jbc.M901104200_bib30) 1996; 70 Hollenhorst (10.1074/jbc.M901104200_bib36) 2007; 21 Song (10.1074/jbc.M901104200_bib49) 2002; 21 Yokoyama (10.1074/jbc.M901104200_bib12) 2003; 202 Zhao (10.1074/jbc.M901104200_bib6) 2006; 281 Stimson (10.1074/jbc.M901104200_bib21) 2002; 277 Nickel (10.1074/jbc.M901104200_bib43) 1995; 23 Cross (10.1074/jbc.M901104200_bib2) 1995; 5 Tate (10.1074/jbc.M901104200_bib5) 1993; 3 Yokomori (10.1074/jbc.M901104200_bib44) 1995; 15 Schmitz (10.1074/jbc.M901104200_bib47) 1997; 272 Yang (10.1074/jbc.M901104200_bib31) 2007; 9 Resendes (10.1074/jbc.M901104200_bib39) 2006; 26 Virbasius (10.1074/jbc.M901104200_bib25) 1991; 11 Brown (10.1074/jbc.M901104200_bib29) 1992; 6 McConnell (10.1074/jbc.M901104200_bib37) 2004; 9 Valouev (10.1074/jbc.M901104200_bib27) 2008; 5 Ammerpohl (10.1074/jbc.M901104200_bib46) 1997; 200 Virmani (10.1074/jbc.M901104200_bib11) 2003; 106 Plass (10.1074/jbc.M901104200_bib1) 2002; 11 Ristevski (10.1074/jbc.M901104200_bib35) 2004; 24 Kapoor-Vazirani (10.1074/jbc.M901104200_bib22) 2008; 68 Cardot (10.1074/jbc.M901104200_bib42) 1994; 33 Hasegawa (10.1074/jbc.M901104200_bib19) 2007; 26 Kang (10.1074/jbc.M901104200_bib40) 2008; 377 Imaki (10.1074/jbc.M901104200_bib41) 2003; 63 Fernandes-Alnemri (10.1074/jbc.M901104200_bib16) 2009; 458 Swigut (10.1074/jbc.M901104200_bib4) 2007; 131 Parsons (10.1074/jbc.M901104200_bib20) 2009; 69 Conway (10.1074/jbc.M901104200_bib8) 2000; 60 Masumoto (10.1074/jbc.M901104200_bib18) 2003; 303 Herman (10.1074/jbc.M901104200_bib3) 2003; 349 Hoare (10.1074/jbc.M901104200_bib33) 1999; 140 Guan (10.1074/jbc.M901104200_bib9) 2003; 107 Parsons (10.1074/jbc.M901104200_bib17) 2006; 25 Atlas (10.1074/jbc.M901104200_bib32) 2001; 20 Rosmarin (10.1074/jbc.M901104200_bib24) 2004; 32 Collard (10.1074/jbc.M901104200_bib7) 2006; 66 Yokomori (10.1074/jbc.M901104200_bib45) 1998; 12 Ohtsuka (10.1074/jbc.M901104200_bib38) 2004; 6 |
References_xml | – volume: 5 start-page: 309 year: 1995 end-page: 314 ident: bib2 publication-title: Curr. Opin. Genet. Dev. – volume: 3 start-page: 226 year: 1993 end-page: 231 ident: bib5 publication-title: Curr. Opin. Genet. Dev. – volume: 69 start-page: 1706 year: 2009 end-page: 1711 ident: bib20 publication-title: Cancer Res. – volume: 293 start-page: 1314 year: 2002 end-page: 1318 ident: bib13 publication-title: Biochem. Biophys. Res. Commun. – volume: 23 start-page: 4785 year: 1995 end-page: 4792 ident: bib43 publication-title: Nucleic Acids Res. – volume: 15 start-page: 5355 year: 1995 end-page: 5362 ident: bib44 publication-title: Mol. Cell Biol. – volume: 22 start-page: 3475 year: 2003 end-page: 3488 ident: bib23 publication-title: Oncogene – volume: 272 start-page: 20850 year: 1997 end-page: 20856 ident: bib47 publication-title: J. Biol. Chem. – volume: 458 start-page: 509 year: 2009 end-page: 513 ident: bib16 publication-title: Nature – volume: 377 start-page: 636 year: 2008 end-page: 646 ident: bib40 publication-title: J. Mol. Biol. – volume: 33 start-page: 12139 year: 1994 end-page: 12148 ident: bib42 publication-title: Biochemistry – volume: 200 start-page: 75 year: 1997 end-page: 84 ident: bib46 publication-title: Gene (Amst.) – volume: 21 start-page: 1048 year: 2002 end-page: 1061 ident: bib49 publication-title: Oncogene – volume: 140 start-page: 2268 year: 1999 end-page: 2279 ident: bib33 publication-title: Endocrinology – volume: 12 start-page: 1241 year: 1998 end-page: 1249 ident: bib45 publication-title: Mol. Endocrinol. – volume: 277 start-page: 4951 year: 2002 end-page: 4958 ident: bib21 publication-title: J. Biol. Chem. – volume: 106 start-page: 198 year: 2003 end-page: 204 ident: bib11 publication-title: Int. J. Cancer – volume: 107 start-page: 202 year: 2003 end-page: 208 ident: bib9 publication-title: Int. J. Cancer – volume: 6 start-page: 2502 year: 1992 end-page: 2512 ident: bib29 publication-title: Genes Dev. – volume: 70 start-page: 2260 year: 1996 end-page: 2268 ident: bib30 publication-title: J. Virol. – volume: 131 start-page: 29 year: 2007 end-page: 32 ident: bib4 publication-title: Cell – volume: 11 start-page: 2479 year: 2002 end-page: 2488 ident: bib1 publication-title: Hum. Mol. Genet. – volume: 32 start-page: 143 year: 2004 end-page: 154 ident: bib24 publication-title: Blood Cells Mol. Dis. – volume: 9 start-page: 5 year: 2004 end-page: 18 ident: bib37 publication-title: Apoptosis – volume: 5 start-page: 829 year: 2008 end-page: 834 ident: bib27 publication-title: Nat. Methods – volume: 68 start-page: 6810 year: 2008 end-page: 6821 ident: bib22 publication-title: Cancer Res. – volume: 202 start-page: 101 year: 2003 end-page: 108 ident: bib12 publication-title: Cancer Lett. – volume: 24 start-page: 5844 year: 2004 end-page: 5849 ident: bib35 publication-title: Mol. Cell Biol. – volume: 60 start-page: 6236 year: 2000 end-page: 6242 ident: bib8 publication-title: Cancer Res. – volume: 20 start-page: 7110 year: 2001 end-page: 7114 ident: bib32 publication-title: Oncogene – volume: 6 start-page: 121 year: 2004 end-page: 128 ident: bib38 publication-title: Nat. Cell Biol. – volume: 303 start-page: 69 year: 2003 end-page: 73 ident: bib18 publication-title: Biochem. Biophys. Res. Commun. – volume: 165 start-page: 1151 year: 2004 end-page: 1161 ident: bib10 publication-title: Am. J. Pathol. – volume: 14 start-page: 1590 year: 2007 end-page: 1604 ident: bib15 publication-title: Cell Death Differ – volume: 25 start-page: 6948 year: 2006 end-page: 6958 ident: bib17 publication-title: Oncogene – volume: 63 start-page: 4607 year: 2003 end-page: 4613 ident: bib41 publication-title: Cancer Res. – volume: 34 start-page: 187 year: 2003 end-page: 192 ident: bib48 publication-title: Nat. Genet. – volume: 26 start-page: 1748 year: 2007 end-page: 1756 ident: bib19 publication-title: Oncogene – volume: 24 start-page: 4954 year: 1996 end-page: 4961 ident: bib26 publication-title: Nucleic Acids Res. – volume: 9 start-page: 339 year: 2007 end-page: 346 ident: bib31 publication-title: Nat. Cell Biol. – volume: 349 start-page: 2042 year: 2003 end-page: 2054 ident: bib3 publication-title: N. Engl. J. Med. – volume: 21 start-page: 1882 year: 2007 end-page: 1894 ident: bib36 publication-title: Genes Dev. – volume: 11 start-page: 5631 year: 1991 end-page: 5638 ident: bib25 publication-title: Mol. Cell Biol. – volume: 66 start-page: 687 year: 2006 end-page: 695 ident: bib7 publication-title: Prostate – volume: 26 start-page: 3060 year: 2006 end-page: 3070 ident: bib39 publication-title: Mol. Cell Biol. – volume: 281 start-page: 30573 year: 2006 end-page: 30580 ident: bib6 publication-title: J. Biol. Chem. – volume: 74 start-page: 4988 year: 2000 end-page: 4998 ident: bib28 publication-title: J. Virol. – volume: 278 start-page: 16863 year: 2003 end-page: 16872 ident: bib34 publication-title: J. Biol. Chem. – volume: 171 start-page: 6154 year: 2003 end-page: 6163 ident: bib14 publication-title: J. Immunol. – volume: 458 start-page: 509 year: 2009 ident: 10.1074/jbc.M901104200_bib16 publication-title: Nature doi: 10.1038/nature07710 – volume: 14 start-page: 1590 year: 2007 ident: 10.1074/jbc.M901104200_bib15 publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4402194 – volume: 20 start-page: 7110 year: 2001 ident: 10.1074/jbc.M901104200_bib32 publication-title: Oncogene doi: 10.1038/sj.onc.1204890 – volume: 281 start-page: 30573 year: 2006 ident: 10.1074/jbc.M901104200_bib6 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M606803200 – volume: 5 start-page: 829 year: 2008 ident: 10.1074/jbc.M901104200_bib27 publication-title: Nat. Methods doi: 10.1038/nmeth.1246 – volume: 140 start-page: 2268 year: 1999 ident: 10.1074/jbc.M901104200_bib33 publication-title: Endocrinology doi: 10.1210/endo.140.5.6710 – volume: 74 start-page: 4988 year: 2000 ident: 10.1074/jbc.M901104200_bib28 publication-title: J. Virol. doi: 10.1128/JVI.74.11.4988-4998.2000 – volume: 171 start-page: 6154 year: 2003 ident: 10.1074/jbc.M901104200_bib14 publication-title: J. Immunol. doi: 10.4049/jimmunol.171.11.6154 – volume: 21 start-page: 1882 year: 2007 ident: 10.1074/jbc.M901104200_bib36 publication-title: Genes Dev. doi: 10.1101/gad.1561707 – volume: 60 start-page: 6236 year: 2000 ident: 10.1074/jbc.M901104200_bib8 publication-title: Cancer Res. – volume: 3 start-page: 226 year: 1993 ident: 10.1074/jbc.M901104200_bib5 publication-title: Curr. Opin. Genet. Dev. doi: 10.1016/0959-437X(93)90027-M – volume: 278 start-page: 16863 year: 2003 ident: 10.1074/jbc.M901104200_bib34 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M213063200 – volume: 22 start-page: 3475 year: 2003 ident: 10.1074/jbc.M901104200_bib23 publication-title: Oncogene doi: 10.1038/sj.onc.1206430 – volume: 12 start-page: 1241 year: 1998 ident: 10.1074/jbc.M901104200_bib45 publication-title: Mol. Endocrinol. doi: 10.1210/mend.12.8.0142 – volume: 24 start-page: 4954 year: 1996 ident: 10.1074/jbc.M901104200_bib26 publication-title: Nucleic Acids Res. doi: 10.1093/nar/24.24.4954 – volume: 70 start-page: 2260 year: 1996 ident: 10.1074/jbc.M901104200_bib30 publication-title: J. Virol. doi: 10.1128/jvi.70.4.2260-2268.1996 – volume: 377 start-page: 636 year: 2008 ident: 10.1074/jbc.M901104200_bib40 publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2008.01.054 – volume: 15 start-page: 5355 year: 1995 ident: 10.1074/jbc.M901104200_bib44 publication-title: Mol. Cell Biol. doi: 10.1128/MCB.15.10.5355 – volume: 303 start-page: 69 year: 2003 ident: 10.1074/jbc.M901104200_bib18 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/S0006-291X(03)00309-7 – volume: 34 start-page: 187 year: 2003 ident: 10.1074/jbc.M901104200_bib48 publication-title: Nat. Genet. doi: 10.1038/ng1158 – volume: 68 start-page: 6810 year: 2008 ident: 10.1074/jbc.M901104200_bib22 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-08-0141 – volume: 165 start-page: 1151 year: 2004 ident: 10.1074/jbc.M901104200_bib10 publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)63376-7 – volume: 6 start-page: 2502 year: 1992 ident: 10.1074/jbc.M901104200_bib29 publication-title: Genes Dev. doi: 10.1101/gad.6.12b.2502 – volume: 349 start-page: 2042 year: 2003 ident: 10.1074/jbc.M901104200_bib3 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra023075 – volume: 24 start-page: 5844 year: 2004 ident: 10.1074/jbc.M901104200_bib35 publication-title: Mol. Cell Biol. doi: 10.1128/MCB.24.13.5844-5849.2004 – volume: 25 start-page: 6948 year: 2006 ident: 10.1074/jbc.M901104200_bib17 publication-title: Oncogene doi: 10.1038/sj.onc.1209684 – volume: 277 start-page: 4951 year: 2002 ident: 10.1074/jbc.M901104200_bib21 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109809200 – volume: 200 start-page: 75 year: 1997 ident: 10.1074/jbc.M901104200_bib46 publication-title: Gene (Amst.) doi: 10.1016/S0378-1119(97)00377-6 – volume: 69 start-page: 1706 year: 2009 ident: 10.1074/jbc.M901104200_bib20 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-08-2351 – volume: 106 start-page: 198 year: 2003 ident: 10.1074/jbc.M901104200_bib11 publication-title: Int. J. Cancer doi: 10.1002/ijc.11206 – volume: 202 start-page: 101 year: 2003 ident: 10.1074/jbc.M901104200_bib12 publication-title: Cancer Lett. doi: 10.1016/j.canlet.2003.08.027 – volume: 11 start-page: 5631 year: 1991 ident: 10.1074/jbc.M901104200_bib25 publication-title: Mol. Cell Biol. – volume: 9 start-page: 5 year: 2004 ident: 10.1074/jbc.M901104200_bib37 publication-title: Apoptosis doi: 10.1023/B:APPT.0000012117.32430.0c – volume: 23 start-page: 4785 year: 1995 ident: 10.1074/jbc.M901104200_bib43 publication-title: Nucleic Acids Res. doi: 10.1093/nar/23.23.4785 – volume: 131 start-page: 29 year: 2007 ident: 10.1074/jbc.M901104200_bib4 publication-title: Cell doi: 10.1016/j.cell.2007.09.026 – volume: 11 start-page: 2479 year: 2002 ident: 10.1074/jbc.M901104200_bib1 publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/11.20.2479 – volume: 21 start-page: 1048 year: 2002 ident: 10.1074/jbc.M901104200_bib49 publication-title: Oncogene doi: 10.1038/sj.onc.1205153 – volume: 293 start-page: 1314 year: 2002 ident: 10.1074/jbc.M901104200_bib13 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/S0006-291X(02)00384-4 – volume: 6 start-page: 121 year: 2004 ident: 10.1074/jbc.M901104200_bib38 publication-title: Nat. Cell Biol. doi: 10.1038/ncb1087 – volume: 107 start-page: 202 year: 2003 ident: 10.1074/jbc.M901104200_bib9 publication-title: Int. J. Cancer doi: 10.1002/ijc.11376 – volume: 5 start-page: 309 year: 1995 ident: 10.1074/jbc.M901104200_bib2 publication-title: Curr. Opin. Genet. Dev. doi: 10.1016/0959-437X(95)80044-1 – volume: 9 start-page: 339 year: 2007 ident: 10.1074/jbc.M901104200_bib31 publication-title: Nat. Cell Biol. doi: 10.1038/ncb1548 – volume: 32 start-page: 143 year: 2004 ident: 10.1074/jbc.M901104200_bib24 publication-title: Blood Cells Mol. Dis. doi: 10.1016/j.bcmd.2003.09.005 – volume: 66 start-page: 687 year: 2006 ident: 10.1074/jbc.M901104200_bib7 publication-title: Prostate doi: 10.1002/pros.20371 – volume: 63 start-page: 4607 year: 2003 ident: 10.1074/jbc.M901104200_bib41 publication-title: Cancer Res. – volume: 272 start-page: 20850 year: 1997 ident: 10.1074/jbc.M901104200_bib47 publication-title: J. Biol. Chem. doi: 10.1074/jbc.272.33.20850 – volume: 26 start-page: 3060 year: 2006 ident: 10.1074/jbc.M901104200_bib39 publication-title: Mol. Cell Biol. doi: 10.1128/MCB.26.8.3060-3070.2006 – volume: 26 start-page: 1748 year: 2007 ident: 10.1074/jbc.M901104200_bib19 publication-title: Oncogene doi: 10.1038/sj.onc.1209965 – volume: 33 start-page: 12139 year: 1994 ident: 10.1074/jbc.M901104200_bib42 publication-title: Biochemistry doi: 10.1021/bi00206a017 |
SSID | ssj0000491 |
Score | 2.0258434 |
Snippet | Epigenetic silencing involving the aberrant DNA methylation of promoter-associated CpG islands is one mechanism leading to the inactivation of tumor suppressor... Epigenetic silencing involving the aberrant DNA methylation of promoter-associated CpG islands is one mechanism leading to the inactivation of tumor suppressor... |
SourceID | pubmedcentral proquest pubmed crossref fao elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 14698 |
SubjectTerms | Base Pairing Base Sequence CARD Signaling Adaptor Proteins Cell Line, Tumor Cytoskeletal Proteins - genetics Cytoskeletal Proteins - metabolism Deoxyribonuclease I - metabolism DNA - metabolism DNA Footprinting DNA Methylation GA-Binding Protein Transcription Factor - metabolism Gene Knockdown Techniques Humans Molecular Sequence Data Promoter Regions, Genetic - genetics Protein Binding Proto-Oncogene Proteins c-ets - metabolism Transcription, Chromatin, and Epigenetics |
Title | Methylation-sensitive Regulation of TMS1/ASC by the Ets Factor, GA-binding Protein-α |
URI | https://dx.doi.org/10.1074/jbc.M901104200 https://www.ncbi.nlm.nih.gov/pubmed/19324871 https://www.proquest.com/docview/67284146 https://pubmed.ncbi.nlm.nih.gov/PMC2685652 |
Volume | 284 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtNAFB2FsoANghZoeM6CwiI4jcePSZapSamogkKToO6smbFTLFE7SpxF-lf8CD_Bj3Dn4UcgkaAby8qMH_E9vnPGc-69CL3xbE6FR3yr22OO5cIAAHuCWIRHnYgQSnwuA4WHn_2zqfvp0rtsNH7VVEurnLfFzda4kttYFX4Du8oo2f-wbHlS-AH2wb6wBQvD9p9sPIzhMWsxm7WUSnSlA7rQ5eUNE5wMx9JZ9ceBYpqAikG-bJ0y_bE-aH3sy8mxCm0ZyZwNSWodBYOjE7tOW6sAMkVddeYmnVukKBhXKntkFTUTBbRuDdrlIsciiYyAQ_oV1hqXTaOskGZ_yKCtdVG2nLN5li2sr-wmWejiU3CTyZptfKvoyWV2UnnEchGqrkg9SbLyVrW4pKgLbMpx1l2iEpQQney9HWuXDSRSxiNc1n060XXnDHh15LNx0basmVkb722XqgQNfw8mwK7kYMJFeygDdMG9qaSqeQ1Z82sFLcmCYeZnV4NqKXUcDQPid4E2A0-4S2AuI53x-ZcqpT1M0XRZR_PXisyi1D3evLTKb6uvs4tE3ZmxbNtU6U_Fb41CTR6iBwZAuK-B_Ag14nQfHfRTlmfXa_wWKzWyssU-uhcU1jpA0604xxXOcTbDEufHgHLM1xhQjgHlWKP8Pa4wjguM__zxGE1PB5PgzDLlQCwBPiS3YsZ7jjfr-F0q16KFgKmB7c86DnO6hHte3HUEIZxSGgnoyO2ZoB0eR7bNYBQl3HmC9tIsjQ8RFtTxhWd34QQRMNgOE07k2QyebRy5jhBNZBXPNxQmV74s2fI9VJoN6oZgmrAyTRO9K_vPdZaYnT3twlyh4biau4aAup3HHIJdQ3YFr2A4HRMpNoBplEOp10SvC2OHYBS52MfSOFstQ5_COwBYb6Kn2vTVjRkQNRHdAEXZQWac32xJk28q87xB8rNbH_kc3a_8wgu0ly9W8Utg9Tl_pd6K32Dn8_o |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Methylation-sensitive+Regulation+of+TMS1%2FASC+by+the+Ets+Factor%2C+GA-binding+Protein-%CE%B1&rft.jtitle=The+Journal+of+biological+chemistry&rft.au=Lucas%2C+Mary+E.&rft.au=Crider%2C+Krista+S.&rft.au=Powell%2C+Doris+R.&rft.au=Kapoor-Vazirani%2C+Priya&rft.date=2009-05-29&rft.pub=American+Society+for+Biochemistry+and+Molecular+Biology&rft.issn=0021-9258&rft.eissn=1083-351X&rft.volume=284&rft.issue=22&rft.spage=14698&rft.epage=14709&rft_id=info:doi/10.1074%2Fjbc.M901104200&rft_id=info%3Apmid%2F19324871&rft.externalDocID=PMC2685652 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9258&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9258&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9258&client=summon |